Specifically, DP9 exhibits robust anti-pancreatic cancer properties, effectively suppressing cell proliferation, inducing apoptosis, arresting the cell cycle at the S phase, and inhibiting angiogenesis and tumor cell migration and invasion. This evidence concerns the gene DPP9 and familial pancreatic carcinoma.